Dexcom (DXCM) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,590.00 |
| Dec 31, 2025 | 1,040.00 |
| Sep 30, 2025 | 971.00 |
| Jun 30, 2025 | 840.00 |
| Mar 31, 2025 | 851.00 |
| Dec 31, 2024 | 983.00 |
| Sep 30, 2024 | 1,983.00 |
| Jun 30, 2024 | 2,344.00 |
| Mar 31, 2024 | 2,358.00 |
| Dec 31, 2023 | 2,667.00 |
| Sep 30, 2023 | 1,118.00 |
| Jun 30, 2023 | 1,402.00 |
| Mar 31, 2023 | 1,530.00 |
| Dec 31, 2022 | 1,762.00 |
| Sep 30, 2022 | 1,505.00 |
| Jun 30, 2022 | 2,041.00 |
| Mar 31, 2022 | 3,842.00 |
| Dec 31, 2021 | 2,926.00 |
| Sep 30, 2021 | 3,097.00 |
| Jun 30, 2021 | 4,204.00 |
| Mar 31, 2021 | 3,581.00 |
| Dec 31, 2020 | 3,621.00 |
| Sep 30, 2020 | 4,131.00 |
| Jun 30, 2020 | 2,236.00 |
| Mar 31, 2020 | 2,376.00 |
| Dec 31, 2019 | 2,373.00 |
| Sep 30, 2019 | 1,645.00 |
| Jun 30, 2019 | 1,751.00 |
| Mar 31, 2019 | 2,229.00 |
| Dec 31, 2018 | 1,991.00 |
| Sep 30, 2018 | 4,317.00 |
| Jun 30, 2018 | 5,532.00 |
| Mar 31, 2018 | 5,517.00 |
| Dec 31, 2017 | 5,982.00 |
| Sep 30, 2017 | 6,049.00 |
| Jun 30, 2017 | 4,226.00 |
| Mar 31, 2017 | 1,453.00 |
| Dec 31, 2016 | 1,792.00 |
| Sep 30, 2016 | 1,452.00 |